A modified poisson regression approach to prospective studies with binary data.
暂无分享,去创建一个
[1] Markku Mikael Nurminen. To use or not to use the odds ratio in epidemiologic analyses? , 1995, European Journal of Epidemiology.
[2] Xiaonan Xue,et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. , 2003, American journal of epidemiology.
[3] T. Cook. Advanced statistics: up with odds ratios! A case for odds ratios when outcomes are common. , 2002, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[4] R. Bender,et al. Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies. , 2002, Journal of clinical epidemiology.
[5] Allan Donner,et al. Design and Analysis of Cluster Randomization Trials in Health Research , 2001 .
[6] John M. Lachin,et al. Biostatistical Methods: The Assessment of Relative Risks , 2000 .
[7] D. Gens,et al. Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Treatment of Severe Traumatic Hemorrhagic Shock: A Randomized Controlled Efficacy Trial , 1999 .
[8] Lisa M. Schwartz,et al. Misunderstandings about the effects of race and sex on physicians' referrals for cardiac catheterization. , 1999, The New England journal of medicine.
[9] J. Zhang,et al. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.
[10] D Kriebel,et al. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? , 1998, Occupational and environmental medicine.
[11] M R Petersen,et al. Prevalence proportion ratios: estimation and hypothesis testing. , 1998, International journal of epidemiology.
[12] S Greenland,et al. Standardized estimates from categorical regression models. , 1995, Statistics in medicine.
[13] D. Consonni,et al. Estimation of prevalence rate ratios from cross-sectional data. , 1995, International journal of epidemiology.
[14] M. Bracken,et al. Clinically useful measures of effect in binary analyses of randomized trials. , 1994, Journal of clinical epidemiology.
[15] N. Jewell,et al. A geometric approach to assess bias due to omitted covariates in generalized linear models , 1993 .
[16] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[17] S. Greenland,et al. Estimating standardized risk differences from odds ratios. , 1991, Biometrics.
[18] D L Sackett,et al. An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.
[19] S Wallenstein,et al. Epidemiologic programs for computers and calculators. Inferences on odds ratios, relative risks, and risk differences based on standard regression programs. , 1987, American journal of epidemiology.
[20] S Greenland,et al. Interpretation and choice of effect measures in epidemiologic analyses. , 1987, American journal of epidemiology.
[21] W D Flanders,et al. Large sample confidence intervals for regression standardized risks, risk ratios, and risk differences. , 1987, Journal of chronic diseases.
[22] R. Royall. Model robust confidence intervals using maximum likelihood estimators , 1986 .
[23] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[24] S Wacholder,et al. Binomial regression in GLIM: estimating risk ratios and risk differences. , 1986, American journal of epidemiology.
[25] J M Robins,et al. Estimation of a common effect parameter from sparse follow-up data. , 1985, Biometrics.
[26] M. Gail,et al. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates , 1984 .
[27] S. Greenland. Limitations of the logistic analysis of epidemiologic data. , 1979, American journal of epidemiology.
[28] J. Cornfield,et al. A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. , 1951, Journal of the National Cancer Institute.